We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
-16.22%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$1.33B
AUM Growth
-$303M
(-19%)
Cap. Flow
-$2.32M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
36.19%
Holding
237
New
8
Increased
84
Reduced
90
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teradyne
TER
|
+$4.42M |
| 2 |
Medtronic
MDT
|
+$1.99M |
| 3 |
Procter & Gamble
PG
|
+$1.78M |
| 4 |
Rockwell Automation
ROK
|
+$1.64M |
| 5 |
Aptiv
APTV
|
+$1.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$9.71M |
| 2 |
PayPal
PYPL
|
+$5.72M |
| 3 |
Unilever
UL
|
+$3.05M |
| 4 |
Amazon
AMZN
|
+$1.36M |
| 5 |
Pacific Biosciences
PACB
|
+$1.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.75% |
| 2 | Technology | 22.62% |
| 3 | Industrials | 13.8% |
| 4 | Communication Services | 10.76% |
| 5 | Consumer Discretionary | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.57T
| $78.3M | 5.87% |
572,439
-64,131
| -10% | -$9.71M |
|
2
Danaher
DHR
$144B
| $58.1M | 4.36% |
258,388
-1,366
| -0.5% | -$315K |
|
3
Mastercard
MA
$493B
| $51.2M | 3.84% |
162,143
-766
| -0.5% | -$264K |
|
4
Microsoft
MSFT
$3.71T
| $49.3M | 3.69% |
191,785
+2,243
| +1% | +$609K |
|
5
Analog Devices
ADI
$190B
| $44.9M | 3.37% |
307,632
-1,091
| -0.4% | -$172K |
|
6
Canadian National Railway
CNI
$76.6B
| $43.8M | 3.28% |
389,355
+5,651
| +1% | +$660K |
|
7
Abbott
ABT
$187B
| $42.4M | 3.18% |
390,215
-1,879
| -0.5% | -$213K |
|
|
8
Rockwell Automation
ROK
$49B
| $40.7M | 3.05% |
204,054
+7,279
| +4% | +$1.64M |
|
9
Alphabet (Google) Class A
GOOGL
$4.33T
| $38.3M | 2.87% |
351,440
+340
| +0.1% | +$40K |
|
10
Nike
NKE
$61.9B
| $35.7M | 2.68% |
349,143
+7,999
| +2% | +$946K |
|
11
Carrier Global
CARR
$52.8B
| $34.2M | 2.56% |
958,419
+28,086
| +3% | +$1.1M |
|
12
NVIDIA
NVDA
$5.42T
| $33.7M | 2.53% |
2,221,450
-23,730
| -1% | -$448K |
|
13
Automatic Data Processing
ADP
$108B
| $31.4M | 2.35% |
149,420
+2,310
| +2% | +$506K |
|
|
NVO
14
Novo Nordisk
NVO
$209B
| $30.3M | 2.27% |
543,406
+9,874
| +2% | +$548K |
|
15
AptarGroup
ATR
$8.61B
| $29.7M | 2.23% |
287,877
-350
| -0.1% | -$38.2K |
|
16
T-Mobile US
TMUS
$190B
| $29.1M | 2.19% |
216,541
+3,876
| +2% | +$506K |
|
17
Walt Disney
DIS
$181B
| $28.6M | 2.14% |
302,444
-1,114
| -0.4% | -$124K |
|
18
Tesla
TSLA
$1.3T
| $27.9M | 2.09% |
124,320
+1,218
| +1% | +$332K |
|
19
CVS Health
CVS
$122B
| $25.5M | 1.92% |
275,571
+11,183
| +4% | +$1.09M |
|
|
20
Alphabet (Google) Class C
GOOG
$4.32T
| $24.1M | 1.81% |
220,160
+2,800
| +1% | +$331K |
|
21
Becton Dickinson
BDX
$48.2B
| $23.6M | 1.77% |
95,803
+2,856
| +3% | +$725K |
|
22
Xylem
XYL
$28.1B
| $23.4M | 1.75% |
298,911
+5,575
| +2% | +$460K |
|
23
Stryker
SYK
$130B
| $23.2M | 1.74% |
116,497
-834
| -0.7% | -$196K |
|
24
Waste Management
WM
$91B
| $21.1M | 1.58% |
138,018
-571
| -0.4% | -$89.4K |
|
25
New York Times
NYT
$10.2B
| $19.9M | 1.5% |
714,519
+19,733
| +3% | +$713K |
|
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
HA
NIM
Reynders McVeigh Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Reynders McVeigh Capital Management held 237 positions worth $1.33B, down 19% from $1.64B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Reynders McVeigh Capital Management's Q2 2022 filing shows 8 new, 84 increased, 90 reduced and 19 closed positions. Its largest new stake was Aptiv: 13,046 shares worth $1.16M. The largest sale was Apple, an estimated $9.71M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.
- Reynders McVeigh Capital Management's largest Q2 2022 buy was Aptiv: 13,046 shares worth $1.16M.
- Reynders McVeigh Capital Management added most to Teradyne in Q2 2022, an estimated $4.42M increase.
- Reynders McVeigh Capital Management's biggest Q2 2022 reduction was Apple, cutting an estimated $9.71M.
- Reynders McVeigh Capital Management fully exited Pacific Biosciences in Q2 2022, selling an estimated $1.03M.
- Reynders McVeigh Capital Management's ten largest holdings make up 36% of its $1.33B portfolio in Q2 2022.
- Reynders McVeigh Capital Management opened 8 new positions and closed 19 in Q2 2022.
- Reynders McVeigh Capital Management's portfolio value fell 19% quarter-over-quarter to $1.33B.
Based on Reynders McVeigh Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.